2019
DOI: 10.1038/s41591-018-0307-0
|View full text |Cite
|
Sign up to set email alerts
|

The practical implementation of artificial intelligence technologies in medicine

Abstract: The development of artificial intelligence (AI)-based technologies in medicine is advancing rapidly, but real-world clinical implementation has not yet become a reality. Here we review some of the key practical issues surrounding the implementation of AI into existing clinical workflows, including data sharing and privacy, transparency of algorithms, data standardization, and interoperability across multiple platforms, and concern for patient safety. We summarize the current regulatory environment in the Unite… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
1,047
0
28

Year Published

2019
2019
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 1,365 publications
(1,080 citation statements)
references
References 22 publications
5
1,047
0
28
Order By: Relevance
“…However, radiomics and ML methods have not been evaluated in terms of their repeatability, which contributes to reservations of making imaging applications that would use prostate MRI more extensively coupled with machine learning in routine clinical practice. High short‐term repeatability is a prerequisite toward quantitative‐tailored treatment planning and therapy monitoring, a major determining factor of the potential role of ML for prostate MRI in routine clinical practice in the future …”
Section: Introductionmentioning
confidence: 99%
“…However, radiomics and ML methods have not been evaluated in terms of their repeatability, which contributes to reservations of making imaging applications that would use prostate MRI more extensively coupled with machine learning in routine clinical practice. High short‐term repeatability is a prerequisite toward quantitative‐tailored treatment planning and therapy monitoring, a major determining factor of the potential role of ML for prostate MRI in routine clinical practice in the future …”
Section: Introductionmentioning
confidence: 99%
“…Situated within the broader context of the implementation of artificial intelligence in the health care system, generative methods can address key concerns regarding data sharing and quality assurance. 39 The current era of "big data" in medicine has the potential to significantly improve patient safety, but concurrently raises major privacy concerns, particularly in the context of data sharing between institutions and the possibility that combining multiple anonymized datasets can allow for re-identification. 22 As the generator network in a GAN has no direct access to the patient images, these models, in combination with differential privacy strategies 40 , can capture the features of a dataset yet be transferred with minimal risk to patient privacy.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, development of software‐based support for PoC decision‐making is crucial for the success of precision medicine. AI might provide such possibilities in the future, though currently, clinical use of AI is hampered by its complexity and issues concerning data sharing, transparency, and patients safety (He et al , ; Topol, ). Nevertheless, the IDx‐DR software program has been approved by the FDA as the first autonomous diagnostic system for screening of diabetic retinopathy without clinical interpretation (He et al , ).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, development of software-based support for PoC decision-making is crucial for the success of precision medicine. AI might provide such possibilities in the future, though currently, clinical use of AI is hampered by its complexity and issues concerning data sharing, transparency, and patients safety (He et al, 2019;Topol, 2019 autonomous diagnostic system for screening of diabetic retinopathy without clinical interpretation (He et al, 2019). Unfortunately, at present, datasets tend to be biased toward accessible organ and cell systems and both the quality of publicly available data and the reproducibility of experiments vary, making interpretation difficult.…”
Section: Discussionmentioning
confidence: 99%